BDBM345266 2-[[1-[(2-Chlorophenyl)methyl]-5-(3- fluorophenyl)pyrazol-3-yl]methoxy]-2- methyl-propanoic acid 1H NMR (CDCl3, 400 MHz) $#948; 1.58 (s, 6H), 4.64 (s, 2H), 5.48 (s, 2H), 6.42 (s, 1H), 6.72-6.85 (m, 1H), 6.88-7.14 (m, 3H), 7.14-7.40 (m, 4H).::US10202350, Example 12::US10214492, Example 12::US11292767, Example 12::US11724989, Example 12

SMILES CC(C)(OCc1cc(-c2cccc(F)c2)n(Cc2ccccc2Cl)n1)C(O)=O

InChI Key InChIKey=DSCSGSGYDAITAF-UHFFFAOYSA-N

Data  11 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 345266   

TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345266(2-[[1-[(2-Chlorophenyl)methyl]-5-(3- fluorophenyl...)
Affinity DataIC50:  5.80E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent